TactiSys Quartz Equipment; Ampere Generator
ABBOTT MEDICAL · Decision date Aug 7, 2026
What did the FDA approve?
FDA records P220013/S033 as a supplement to PMA P220013, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Aug 7, 2026.
FDA approval order statement
approval for firmware changes to the TactiSys Quartz Equipment v1.8.0 and Ampere Generator v1.2.0 to maintain compatibility with the TactiFlex Duo Ablation Catheter, Sensor Enabled
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 7, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P220013/S033
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- OAE
- Decision code
- APPR
- Decision date
- Aug 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.
- Applicant
- Abbott Medical
- Product code
- OAE
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220013. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220013 · Original PMA
TactiFlex Ablation Catheter, Sensor Enabled, TactiSys Quartz Equipment, TactiSys Quartz, TactiFlex Radiofrequency C
P220013/S020 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
P220013/S021 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
P220013/S023 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE)
P220013/S025 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE)
P220013/S026 · Related supplement
TactiFlex Sensor Enabled
P220013/S027 · Related supplement
TactiFlex Ablation Catheter SE (A-TFSE-D, A-TFSE-F, A-TFSE-J, A-TFSE-DD, A-TFSE-DF, A-TFSE-FF, A-TFSE-FJ, A-TFSE-JJ, A-T
P220013/S033 received
Application receipt date recorded by FDA.
P220013/S029 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (A-TFSE-D; A-TFSE-F; A-TFSE-J; A-TFSE-DD; A-TFSE-DF; A-TFSE-FF; A-TFSE-FJ;
P220013/S022 · Related supplement
TactiFlex Sensor Enabled Ablation Catheter
P220013/S032 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE)
P220013/S031 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
P220013/S030 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled, TactiSys Quartz Equipment, TactiSys Quartz, TactiFlex Radiofrequency C
P220013/S033 · FDA decision
Real-Time Process
P220013/S028 · Related supplement
TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDM
P220013/S034 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
Timeline entries are records held by MedtechLedger for P220013. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220013
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | May 18, 2023 | FDA | |
TactiFlex Ablation Catheter, Sensor EnabledP220013/S020 | ABBOTT MEDICAL | PMA supplement | Aug 1, 2025 | FDA |
TactiFlex Ablation Catheter, Sensor EnabledP220013/S021 | ABBOTT MEDICAL | PMA supplement | Aug 7, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jan 8, 2026 | FDA | |
TactiFlex Sensor EnabledP220013/S026 | ABBOTT MEDICAL | PMA supplement | Jan 15, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 3, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | May 15, 2026 | FDA | |
TactiFlex Sensor Enabled Ablation CatheterP220013/S022 | ABBOTT MEDICAL | PMA supplement | May 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | May 29, 2026 | FDA | |
TactiFlex Ablation Catheter, Sensor EnabledP220013/S031 | ABBOTT MEDICAL | PMA supplement | Jun 5, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jul 23, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 4, 2026 | FDA | |
TactiFlex Ablation Catheter, Sensor EnabledP220013/S034 | ABBOTT MEDICAL | PMA supplement | Sep 22, 2026 | FDA |
Explore the linked device profile
Other records with product code OAE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
STOP Persistent AFP100010/S154 | Medtronic Cryocath, LP | PMA supplement | Sep 25, 2026 | FDA |
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
QDOT MICRO SystemP210027/S018 | Biosense Webster, Inc. | PMA supplement | Sep 10, 2026 | FDA |
TX eco CableP210027/S017 | Biosense Webster, Inc. | PMA supplement | Aug 17, 2026 | FDA |
TactiSys Quartz Equipment; Ampere GeneratorP130026/S102 | St Jude Medical | PMA supplement | Aug 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 5050 Nathan Ln. N., Plymouth, MN, 55442
Sources and methodology
- Original FDA record: P220013/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


